US › Healthcare

Seelos Therapeutics, Inc. (SEELQ)

US · Healthcare · Biotechnology

$0.000.00%

Last close · 2026-08-04

Latest quarter · ended 2024-06-30

Revenue

Net profit

$1.7M

Profit YoY

+105.8%

EPS

$1.98

EPS estimate

$-0.05

EPS came in at 1.98 against a street estimate of -0.05 — a beat of 4060.0%.

Key statistics

Market cap

$58

P/E

0.0

Forward P/E

0.0

P/B

0.00

Book value

$-135.50

EPS (TTM)

$0.20

52-week high

$0.00

52-week low

$0.00

50-day MA

$0.00

200-day MA

$0.00

Beta

4.92

Shareholding

Insiders

10.66%

Institutions

8.80%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Seelos Therapeutics, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.